ALEMTUZUMAB for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,604 adverse event reports in the FDA FAERS database where ALEMTUZUMAB was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for ALEMTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 1,808 | 12.8% | 44 | 700 |
| Fatigue | 1,744 | 12.3% | 30 | 640 |
| Pyrexia | 1,441 | 10.2% | 114 | 837 |
| Off label use | 1,259 | 8.9% | 275 | 274 |
| Rash | 1,094 | 7.7% | 28 | 387 |
| Nausea | 1,053 | 7.4% | 28 | 424 |
| Dyspnoea | 855 | 6.0% | 44 | 425 |
| Lymphocyte count decreased | 852 | 6.0% | 15 | 259 |
| Asthenia | 841 | 5.9% | 29 | 422 |
| Multiple sclerosis relapse | 836 | 5.9% | 14 | 391 |
| Urinary tract infection | 746 | 5.3% | 36 | 420 |
| Drug ineffective | 715 | 5.1% | 139 | 219 |
| Pain | 705 | 5.0% | 15 | 290 |
| Condition aggravated | 623 | 4.4% | 42 | 276 |
| Malaise | 621 | 4.4% | 24 | 279 |
Other Indications for ALEMTUZUMAB
Multiple sclerosis (4,389)
Bone marrow conditioning regimen (1,122)
Immunosuppressant drug therapy (594)
Product used for unknown indication (416)
Relapsing multiple sclerosis (350)
Chronic lymphocytic leukaemia (315)
Prophylaxis against graft versus host disease (277)
Immunosuppression (261)
Stem cell transplant (235)
Allogenic stem cell transplantation (202)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)
TECFIDERA (806)